U.S. Army starts clinical testing trial for its OWN COVID-19 vaccine

The U.S. Army has launched clinical testing for its ‘next-generation’ COVID-19 vaccine that’s designed to protect against the pandemic virus, its variants and other coronaviruses.  In early tests, the shot appears to prompt high levels of antibodies that should block the older ‘wild-type’ coronavirus, three major variants and even SARS-CoV-1, the similar pathogen that triggered … Read more

Mum shares how her toddler has helped her cope with her clinical OCD

A first-time mother has shared how her young daughter helps her cope with her obsession to clean and organise her home.  Tiffany Norman, 36, from New South Wales, has been living with obsessive-compulsive disorder since she was nine, but was only formally diagnosed in 2019.  Tiffany said physicians were uncertain what exactly caused the condition … Read more

Pfizer launches first clinical trial of PILL to treat COVID-19 orally

Pfizer launches first clinical trial of a PILL to treat COVID-19 that prevents the virus from making copies of itself inside human cells Pfizer Inc has launched early-stage human trials of an experimental oral drug to treat coronavirus called PF-07321332 It belongs to a class of drugs called protease inhibitors, which would inhibit an enzyme … Read more

Pfizer launches first clinical trial of a PILL to treat COVID-19

Pfizer launches first clinical trial of a PILL to treat COVID-19 that prevents the virus from making copies of itself inside human cells Pfizer Inc has launched early-stage human trials of an experimental oral drug to treat coronavirus called PF-07321332 It belongs to a class of drugs called protease inhibitors, which would inhibit an enzyme … Read more

U.S. data for AstraZeneca’s COVID-19 vaccine clinical trial is under review by independent advisors

Long-awaited results from AstraZeneca Plc’s U.S coronavirus vaccine trial are currently being reviewed by independent advisors to determine whether the shot is safe and effective. Dr Francis Collins, director of the National Institutes of Health (NIH), said the drug company and its partner, the University of Oxford, completed enrollment of 30,000 participants earlier this year.  … Read more

Johnson & Johnson reveals its Covid vaccine is 66% effective in clinical trial

Johnson and Johnson’s coronavirus vaccine is 66 per cent effective against the disease, early trial results reveal. And it was shown to prevent severe cases of the virus in 86 per cent of cases – with no participants who were vaccinated needing hospital treatment or dying 28 days after the dose was administered.  The jab … Read more

Novavax will submit results to UK regulator ‘within two weeks’, clinical trial chief says

The Novavax coronavirus vaccine could submit its results to the UK regulator within two weeks, says the clinical trial chief, with supplies set to be available this summer. Early results show the jab is 89.3 effective against the virus including the Kent strain in a glimmer of hope the UK could add a fourth jab … Read more

Pfizer claims coronavirus vaccine is 90% effective in clinical trial

One of the leading coronavirus vaccine candidates has proven to be 90 per cent effective, marking a major breakthrough in the global race to stop the disease.  Pfizer and BioNTech today said that early results from a massive clinical trial suggest nine out of 10 people who get their jab are protected from coronavirus by … Read more

Heavily-pregnant clinical fellow shares moving clip to her unborn child ‘just in case’

A heavily-pregnant doctor has shared an emotional video to her unborn child ‘just in case’ she dies of COVID-19 before the baby is born.  Dr Meenal Viz, a clinical fellow in medicine based in London, posted the moving footage to her social media accounts, showing images of life before and during the pandemic. Dr Viz, … Read more

NIH begins clinical trial of hydroxychloroquine and azithromycin to treat coronavirus patients

NIH doses first coronavirus patient in trial of hydroxychloroquine and antibiotic combo touted by Trump in hopes the controversial drug will cut risks of hospitalization and death The NIH has begun a clinical trial testing anti-malaria drug hydroxychloroquine and antibiotic azithromycin in coronavirus patients Patients will either be assigned the experimental treatment or a pair … Read more